Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies

被引:40
|
作者
Lin, Richard J. [1 ]
Elko, Theresa A. [1 ]
Devlin, Sean M. [2 ]
Shahrokni, Armin [3 ,4 ]
Jakubowski, Ann A. [1 ,4 ]
Dahi, Parastoo B. [1 ,4 ]
Perales, Miguel-Angel [1 ,4 ]
Tamari, Roni [1 ,4 ]
Shaffer, Brian C. [1 ,4 ]
Sauter, Craig S. [1 ,4 ]
Papadopoulos, Esperanza B. [1 ,4 ]
Gyurkocza, Boglarka [1 ,4 ]
Korc-Grodzicki, Beatriz [3 ,4 ]
Barker, Juliet N. [1 ,4 ]
Maloy, Molly A. [1 ]
Giralt, Sergio A. [1 ,4 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Adult BMT Serv, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med, Geriatr Serv, 1275 York Ave, New York, NY 10021 USA
[4] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA
基金
美国国家卫生研究院;
关键词
ACUTE MYELOID-LEUKEMIA; COMORBIDITY INDEX; RISK-ASSESSMENT; SURVIVAL; AGE; VALIDATION; FERRITIN; ALBUMIN;
D O I
10.1038/s41409-019-0654-6
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Older patients are at increased risk for complications and death following allogeneic hematopoietic cell transplantation (allo-HCT). Traditional transplant-specific prognostic indices such as hematopoietic cell transplant comorbidity index (HCT-CI) may not capture all underlying geriatric vulnerabilities, and in-depth evaluation by a geriatrician prior to transplant may not always be available. We hypothesize that routine pretransplant interdisciplinary clinical assessment may uncover prognostically important geriatric deficits. Using an institutional database of 457 adults aged 60 years and older who underwent first allo-HCT for hematological malignancies from 2010 to 2017, we examined the prognostic impact of pretransplant deficits in geriatric domains of function, mobility, mood, medication, nutrition, and relevant biochemical markers. We found that impairment in instrumental activities of daily living (IADL) was associated with reduced survival through increased nonrelapse mortality (NRM, HR=1.82; 95% CI, 1.04-3.19). The combination of IADL impairment with either HCT-CI/age index or disease risk index readily stratified NRM and overall survival, respectively. In addition, we found that even mild renal dysfunction adversely impacted survival in older transplant patients. Our findings establish important geriatric vulnerabilities in older patients prior to allo-HCT and may provide an entry point for prospective, interventional trials to improve their outcomes.
引用
收藏
页码:157 / 164
页数:8
相关论文
共 50 条
  • [31] Burden and Impact of Geriatric Syndromes Associated with Allogeneic Hematopoietic Cell Transplantation in Older Adults
    Lin, Richard J.
    Elko, Theresa A.
    Hilden, Patrick
    Dahi, Parastoo B.
    Jakubowski, Ann A.
    Perales, Miguel-Angel
    Barker, Juliet
    Castro-Malaspina, H. R.
    Shaffer, Brian C.
    Shahrokni, Armin
    Tamari, Roni
    Papadopoulos, Esperanza B.
    Sauter, Craig S.
    Maloy, Molly
    Korc-Grodzicki, Beatriz
    Giralt, Sergio
    BLOOD, 2018, 132
  • [32] Clinical options after failure of allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies
    Petrovic, Aleksandra
    Hale, Gregory
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (04) : 515 - 527
  • [33] Second Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies for Relapse After First Allografts
    Gyurkocza, Boglarka
    Storb, Rainer
    Chauncey, Thomas
    Maloney, David G.
    Storer, Barry
    Sandmaier, Brenda M.
    BLOOD, 2012, 120 (21)
  • [34] Factors Predictive of Relapse of Hematologic Malignancies in Pediatric Patients Post Allogeneic Hematopoietic Cell Transplantation
    Shah, Nirali N.
    Borowitz, Michael J.
    Steinberg, Seth M.
    Lefell, Mary
    Robey, Nancy
    Gamper, Christopher
    Symons, Heather J.
    Loeb, David
    Wayne, Alan S.
    Chen, Allen R.
    BLOOD, 2012, 120 (21)
  • [35] Iron overload in hematologic malignancies and outcome of allogeneic hematopoietic stem cell transplantation
    Koreth, John
    Antin, Joseph H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (03): : 364 - 366
  • [36] A Simple Geriatric Vulnerability Index for Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
    Lin, Richard J.
    Elko, Theresa A.
    Devlin, Sean M.
    Jakubowski, Ann A.
    Shahrokni, Armin
    Dahi, Parastoo B.
    Perales, Miguel-Angel
    Tamari, Roni
    Shaffer, Brian C.
    Sauter, Craig S.
    Papadopoulos, Esperanza B.
    Castro-Malaspina, H. R.
    Barker, Juliet
    Maloy, Molly
    Korc-Grodzicki, Beatriz
    Giralt, Sergio
    BLOOD, 2018, 132
  • [37] Allogeneic hematopoietic cell transplantation for older patients
    Lin, Richard J.
    Artz, Andrew S.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2021, (01) : 254 - 263
  • [38] Comparative outcomes of nonablative and ablative allogeneic hematopoietic stem cell transplantation for patients with hematologic malignancies younger than 50 years
    Kim, HG
    Kim, I
    Kim, BS
    Kim, JS
    Hong, YS
    Yoon, SS
    Lee, JS
    Park, S
    Kim, BK
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 45 - 45
  • [39] Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies improved outcomes over two decades
    Cooper, Jason P.
    Storer, Barry E.
    Granot, Noa
    Gyurkocza, Boglarka
    Sorror, Mohamed L.
    Chauncey, Thomas R.
    Shizuru, Judith
    Franke, Georg-Nikolaus
    Maris, Michael B.
    Boyer, Michael
    Bruno, Benedetto
    Sahebi, Firoozeh
    Langston, Amelia A.
    Hari, Parameswaran
    Agura, Edward D.
    Petersen, Soren Lykke
    Maziarz, Richard T.
    Bethge, Wolfgang
    Asch, Julie
    Gutman, Jonathan A.
    Olesen, Gitte
    Yeager, Andrew M.
    Hubel, Kai
    Hogan, William J.
    Maloney, David G.
    Mielcarek, Marco
    Martin, Paul J.
    Flowers, Mary E. D.
    Georges, George E.
    Woolfrey, Ann E.
    Deeg, H. Joachim
    Scott, Bart L.
    McDonald, George B.
    Storb, Rainer
    Sandmaier, Brenda M.
    HAEMATOLOGICA, 2021, 106 (06) : 1599 - 1607
  • [40] Coping in Patients with Hematologic Malignancies Undergoing Hematopoietic Cell Transplantation
    Newcomb, Richard
    Amonoo, Hermioni L.
    Nelson, Ashley M.
    Choe, Joanna
    Holmbeck, Katherine
    Nably, Anisa
    Lee, Stephanie J.
    LeBlanc, Thomas W.
    El-Jawahri, Areej
    BLOOD, 2023, 142